RS12878001 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Metabolite levels (myristoyl sphingomyelin; sphingomyelin (d18:1/14:0, d16:1/16:0); C14:0 SM; C14_0_SM) | G | OR: 0.39 | 9E-110 | PubMed |
| Metabolite levels (sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0)) | G | OR: 0.32 | 1E-45 | PubMed |
| Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels | G | OR: 0.35 | 8E-36 | PubMed |
| Metabolite levels (sphingomyelin (d18:1/21:0, d17:1/22:0, d16:1/23:0)) | G | OR: 0.27 | 1E-32 | PubMed |
| Mean platelet volume | T | β: 0.029 | 1E-28 | PubMed |
| Metabolite levels (sphingomyelin (d18:1/20:0, d16:1/22:0); C20:0 SM) | G | OR: 0.22 | 2E-28 | PubMed |
| Sphingomyelin(32:1)_[M+H]1+ levels | G | β: 0.075 | 4E-26 | PubMed |
| Sphingomyelin(32:1)_[M-CH3]1- levels | T | OR: 0.1 | 5E-26 | PubMed |
| Triglyceride levels | — | — | 5E-24 | PubMed |
| Plasma ceramide (d16:1/24:1, d18:1/22:1)* levels in chronic kidney disease | G | OR: 0.24 | 2E-23 | PubMed |
| Sphingomyelin (d18:2/21:0, d16:2/23:0) levels | G | OR: 0.28 | 1E-22 | PubMed |
| Mean platelet volume | G | β: 0.03 | 6E-22 | PubMed |
| Sphingomyelin (d18:1/20:2, d18:2/20:1, d16:1/22:2) levels | G | OR: 0.27 | 3E-21 | PubMed |
| Metabolite levels (sphingomyelin (d17:2/16:0, d18:2/15:0)) | G | OR: 0.21 | 4E-21 | PubMed |
| Metabolite levels (sphingomyelin (d18:1/19:0, d19:1/18:0)) | G | OR: 0.21 | 9E-21 | PubMed |
| Metabolite levels (euricoyl sphingomyelin; sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1); C22:1 SM; C22_1_SM) | G | OR: 0.16 | 3E-19 | PubMed |
| Triglyceride levels | G | β: 0.021 | 5E-19 | PubMed |
| Platelet count | G | — | 1E-17 | PubMed |
| Platelet count | G | β: 0.021 | 3E-17 | PubMed |
| Sphingomyelin (d17:1/24:1) levels | G | OR: 0.25 | 1E-16 | PubMed |